UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival

Authors

Ruth Nousiainen, University of Helsinki
Katja Eloranta, University of Helsinki
Noora Isoaho, KTH Royal Institute of Technology
Stefano Cairo, Champions Oncology, Hackensack
David B Wilson, Washington University School of Medicine in St. Louis
Markku Heikinheimo, Washington University School of Medicine in St. Louis
Marjut Pihlajoki, University of Helsinki

Journal

Frontiers in Genetics

Publication Date

1-1-2023

Volume

14

First Page

1170940

Document Type

Open Access Publication

DOI

10.3389/fgene.2023.1170940

Rights and Permissions

Nousiainen R, Eloranta K, Isoaho N, Cairo S, Wilson DB, Heikinheimo M and Pihlajoki M (2023) UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival. Front. Genet. 14:1170940. doi: 10.3389/fgene.2023.1170940 © 2023 Nousiainen, Eloranta, Isoaho, Cairo, Wilson, Heikinheimo and Pihlajoki. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Recommended Citation

Nousiainen, Ruth; Eloranta, Katja; Isoaho, Noora; Cairo, Stefano; Wilson, David B; Heikinheimo, Markku; and Pihlajoki, Marjut, "UBE2C expression is elevated in hepatoblastoma and correlates with inferior patient survival." Frontiers in Genetics. 14, 1170940 (2023).
https://digitalcommons.wustl.edu/oa_4/2926

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.